Shandong Buchang Pharmaceuticals' low P/S ratio may reflect ...

Shandong Buchang Pharmaceuticals' low P/S ratio may reflect expectations of continued disappointing revenue performance. The company's declining revenue and predicted industry growth could challenge its current P/S ratio, potentially disappointing shareholders. Current investor sentiment and future expectations do not seem to justify a higher P/S ratio for the company.